CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study

Introduction Sarcoidosis is a multisystem disease, predominantly affecting the lungs but can involve the heart, resulting in cardiac sarcoidosis (CS). Patients require MRI/Positron Emission Tomography (PET) scans for diagnosis. Echocardiography, ECG and Holter monitoring may be indicative but not di...

Full description

Bibliographic Details
Main Authors: Ajit Lalvani, Katharine Tweed, Lynne Williams, Mark Toshner, Juan Carlos Quijano-Campos, Sharad Agarwal, Yi-Da Chiu, Kane Dorey, Thomas Devine, Victoria Stoneman
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/7/1/e000608.full
id doaj-20a645ae43d343c98f0524d9f4f4f79c
record_format Article
spelling doaj-20a645ae43d343c98f0524d9f4f4f79c2021-02-01T14:31:07ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392020-05-017110.1136/bmjresp-2020-000608CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort studyAjit Lalvani0Katharine Tweed1Lynne Williams2Mark Toshner3Juan Carlos Quijano-Campos4Sharad Agarwal5Yi-Da Chiu6Kane Dorey7Thomas Devine8Victoria Stoneman93 Department of Medicine, Imperial College London, London, UK Department of Radiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKRoyal Papworth Hospital NHS Foundation TrustPulmonary Vascular Disease Unit, Royal Papworth Hospital NHS foundation Trust, Cambridge, Cambridgeshire, United KingdomInterstitial Lung Disease Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKDepartment of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKResearch & Development, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKInterstitial Lung Disease Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKResearch & Development, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKResearch & Development, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UKIntroduction Sarcoidosis is a multisystem disease, predominantly affecting the lungs but can involve the heart, resulting in cardiac sarcoidosis (CS). Patients require MRI/Positron Emission Tomography (PET) scans for diagnosis. Echocardiography, ECG and Holter monitoring may be indicative but not diagnostic alone. Patients can present late with conduction defects, heart failure or sudden death. The CASPA (CArdiac Sarcoidosis in PApworth) study protocol aims to (1) use MRI to identify CS prevalence; (2) use speckle-tracking echocardiography, signal averaged ECG and Holter monitoring to look for diagnostic pathways; and (3) identify serum proteins which may be associated with CS.Methods and analysis Participants with pulmonary sarcoidosis (and no known cardiac disease) from Royal Papworth Hospital will have the following: cardiac MRI with late gadolinium, two-dimensional transthoracic echocardiography with speckle tracking, signal averaged ECG and 24-hour Holter monitor. They will provide a serum sample for brain natriuretic peptide levels and proteomics by liquid chromatography coupled to high-resolution mass spectrometry. All data will be collected on OpenClinica platform and analysed approximately 6 months after final patient recruitment.Ethics and dissemination The Camden & Kings Cross Research Ethics Committee approved the protocol (REC number: 17/LO/0667). Integrated Research Approval System (IRAS) 222 720. Dissemination of findings will be via conference presentations and submitted to peer-reviewed journals.https://bmjopenrespres.bmj.com/content/7/1/e000608.full
collection DOAJ
language English
format Article
sources DOAJ
author Ajit Lalvani
Katharine Tweed
Lynne Williams
Mark Toshner
Juan Carlos Quijano-Campos
Sharad Agarwal
Yi-Da Chiu
Kane Dorey
Thomas Devine
Victoria Stoneman
spellingShingle Ajit Lalvani
Katharine Tweed
Lynne Williams
Mark Toshner
Juan Carlos Quijano-Campos
Sharad Agarwal
Yi-Da Chiu
Kane Dorey
Thomas Devine
Victoria Stoneman
CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
BMJ Open Respiratory Research
author_facet Ajit Lalvani
Katharine Tweed
Lynne Williams
Mark Toshner
Juan Carlos Quijano-Campos
Sharad Agarwal
Yi-Da Chiu
Kane Dorey
Thomas Devine
Victoria Stoneman
author_sort Ajit Lalvani
title CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
title_short CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
title_full CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
title_fullStr CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
title_full_unstemmed CASPA (CArdiac Sarcoidosis in PApworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
title_sort caspa (cardiac sarcoidosis in papworth) improving the diagnosis of cardiac involvement in patients with pulmonary sarcoidosis: protocol for a prospective observational cohort study
publisher BMJ Publishing Group
series BMJ Open Respiratory Research
issn 2052-4439
publishDate 2020-05-01
description Introduction Sarcoidosis is a multisystem disease, predominantly affecting the lungs but can involve the heart, resulting in cardiac sarcoidosis (CS). Patients require MRI/Positron Emission Tomography (PET) scans for diagnosis. Echocardiography, ECG and Holter monitoring may be indicative but not diagnostic alone. Patients can present late with conduction defects, heart failure or sudden death. The CASPA (CArdiac Sarcoidosis in PApworth) study protocol aims to (1) use MRI to identify CS prevalence; (2) use speckle-tracking echocardiography, signal averaged ECG and Holter monitoring to look for diagnostic pathways; and (3) identify serum proteins which may be associated with CS.Methods and analysis Participants with pulmonary sarcoidosis (and no known cardiac disease) from Royal Papworth Hospital will have the following: cardiac MRI with late gadolinium, two-dimensional transthoracic echocardiography with speckle tracking, signal averaged ECG and 24-hour Holter monitor. They will provide a serum sample for brain natriuretic peptide levels and proteomics by liquid chromatography coupled to high-resolution mass spectrometry. All data will be collected on OpenClinica platform and analysed approximately 6 months after final patient recruitment.Ethics and dissemination The Camden & Kings Cross Research Ethics Committee approved the protocol (REC number: 17/LO/0667). Integrated Research Approval System (IRAS) 222 720. Dissemination of findings will be via conference presentations and submitted to peer-reviewed journals.
url https://bmjopenrespres.bmj.com/content/7/1/e000608.full
work_keys_str_mv AT ajitlalvani caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT katharinetweed caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT lynnewilliams caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT marktoshner caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT juancarlosquijanocampos caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT sharadagarwal caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT yidachiu caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT kanedorey caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT thomasdevine caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
AT victoriastoneman caspacardiacsarcoidosisinpapworthimprovingthediagnosisofcardiacinvolvementinpatientswithpulmonarysarcoidosisprotocolforaprospectiveobservationalcohortstudy
_version_ 1724315296391495680